Diabetes Care Management Programs and Protocols
Diabetes care management encompasses the structured clinical, behavioral, and administrative protocols used to coordinate ongoing treatment for individuals living with Type 1, Type 2, or gestational diabetes mellitus. These programs operate across payer, provider, and health system settings and are governed by overlapping federal standards, clinical guidelines, and quality measurement frameworks. Understanding how these programs are structured — and where their boundaries lie — is essential for care teams, health plans, and administrators responsible for managing diabetic populations at scale.
Definition and scope
Diabetes care management programs are systematic, population-level interventions designed to support glycemic control, prevent complications, and reduce avoidable utilization among individuals with a diabetes diagnosis. They are distinct from episodic diabetes treatment in that they maintain longitudinal engagement with patients over time, tracking clinical indicators and coordinating across disciplines.
The scope of these programs spans chronic disease care management protocols, self-management education, medication adherence support, comorbidity coordination (particularly cardiovascular disease, chronic kidney disease, and depression), and care transitions. The American Diabetes Association (ADA) publishes annual Standards of Medical Care in Diabetes, which defines evidence thresholds for HbA1c targets (generally below 7% for most non-pregnant adults), blood pressure goals, and lipid management benchmarks that structured programs use as reference points.
From a regulatory standpoint, the Centers for Medicare & Medicaid Services (CMS) recognizes diabetes-specific management activities under several billing frameworks, including Chronic Care Management (CCM) under CPT code 99490 and the Medicare Diabetes Prevention Program (MDPP), which was granted Medicare coverage through the Physician Fee Schedule starting in 2018 (CMS MDPP Final Rule, 82 FR 52976). The National Committee for Quality Assurance (NCQA) Diabetes Recognition Program provides an accreditation pathway for clinician practices meeting structured care delivery criteria.
How it works
Diabetes care management programs typically follow a phased operational structure built around four discrete functions:
-
Identification and risk stratification — Eligible individuals are identified through claims data, EHR flags, or health risk assessments. Risk stratification in care management tools categorize patients by glycemic control status, complication burden, and social risk factors. High-complexity patients with HbA1c above 9%, end-organ involvement, or three or more comorbidities are typically routed to intensive case management tracks.
-
Care planning — A patient-centered care plan is developed in collaboration with the patient and the care team. The plan documents individualized glycemic targets, medication regimens, self-monitoring frequency, dietary parameters, physical activity goals, and referral needs (endocrinology, ophthalmology, podiatry, nephrology).
-
Ongoing monitoring and outreach — Care managers conduct scheduled touchpoints — typically monthly for high-risk patients — to review self-reported blood glucose logs, medication side effects, and lifestyle adherence. Telehealth and remote care management platforms are increasingly integrated into this phase, enabling continuous glucose monitor (CGM) data review between visits.
-
Coordination and escalation — When clinical thresholds are breached (e.g., HbA1c elevation above target, new proteinuria, or foot ulcer development), the care manager initiates referral or escalation pathways to the supervising physician or specialist. Coordination protocols align with the interdisciplinary care teams model, which typically includes a nurse care manager, registered dietitian, pharmacist, and behavioral health liaison.
The ADA's Standards of Medical Care in Diabetes (updated annually, accessible via diabetes.org) and the Agency for Healthcare Research and Quality (AHRQ) Diabetes Care Quality Improvement toolkit both provide structured protocol frameworks that programs use to standardize these phases.
Common scenarios
Diabetes care management programs encounter three primary patient scenarios that require differentiated protocol application:
Type 2 diabetes with poor glycemic control — The highest-volume scenario. Patients with HbA1c above 9% and no current endocrinology follow-up are flagged for intensive outreach. Care managers assess for medication access barriers, food insecurity, and health literacy gaps before escalating to clinical adjustment. Social determinants of health in care management screening tools — such as the AHC Health-Related Social Needs Screening Tool developed through CMS's Accountable Health Communities model — are applied at intake.
Type 1 diabetes with recurrent hypoglycemia — This subpopulation requires specialized protocol attention. Care managers coordinate CGM review, glucagon prescription verification, and endocrinology touchpoints. The clinical risk profile differs fundamentally from Type 2: insulin dependence creates hypoglycemic exposure that oral antidiabetic agents do not.
Gestational diabetes mellitus (GDM) — Programs managing GDM operate under a compressed timeline with distinct postpartum transition requirements. The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 190 specifies that postpartum glucose testing should occur at 4–12 weeks after delivery. Care management protocols must include a handoff plan for ongoing Type 2 diabetes screening, as 50% of individuals with GDM develop Type 2 diabetes within 5–10 years (ACOG Practice Bulletin No. 190).
Decision boundaries
Not all diabetes-related care coordination constitutes formal care management. Programs must apply classification boundaries to avoid regulatory misalignment and billing errors.
Care management vs. disease management — Disease management programs (DMPs) are typically telephonic, protocol-driven, and population-facing. Formal care management, as defined by CMS CCM criteria, requires a documented care plan, a designated care team member, and a minimum of 20 minutes of non-face-to-face time per calendar month. These are distinct billing and operational categories.
Complexity thresholds — Standard CCM (CPT 99490) applies to patients with two or more chronic conditions. Complex Chronic Care Management (CPT 99487) applies when 60 or more minutes of clinical staff time are required monthly and when moderate-to-high complexity medical decision-making is involved. Diabetes with active nephropathy, retinopathy, or neuropathy typically qualifies for the complex tier. Complex care management protocols apply when multiple organ systems are involved simultaneously.
Scope of practice boundaries — Care managers — regardless of credential level — do not independently adjust medication regimens, order diagnostic tests, or make diagnoses. Protocol deviations that require clinical judgment must be escalated to the supervising provider. The care manager roles and responsibilities framework, as outlined by the Case Management Society of America (CMSA) Standards of Practice for Case Management (2022 revision), delineates these boundaries explicitly.
Medicare care management programs and value-based care and care management frameworks further define how diabetes management activities are measured, reported, and reimbursed within payer contracts — particularly under HEDIS measures tracked by NCQA, which include Comprehensive Diabetes Care (CDC) as a core quality indicator.
References
- American Diabetes Association – Standards of Medical Care in Diabetes
- CMS Medicare Diabetes Prevention Program (MDPP) – Federal Register Final Rule, 82 FR 52976
- CMS Chronic Care Management – CPT Code Guidance
- NCQA Diabetes Recognition Program
- AHRQ Diabetes Care Quality Improvement Resources
- ACOG Practice Bulletin No. 190 – Gestational Diabetes Mellitus
- Case Management Society of America (CMSA) – Standards of Practice for Case Management, 2022
- CMS Accountable Health Communities Model – AHC HRSN Screening Tool